Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
4.400
+0.100 (2.33%)
Nov 5, 2025, 3:40 PM EST - Market open
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $743.7 million as of November 5, 2025. Its market cap has increased by 33.37% in one year.
Market Cap
743.70M
Enterprise Value
761.69M
1-Year Change
33.37%
Ranking
Category
Stock Price
$4.40
Market Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $743.70M, a decrease of -54.30%. That is a compound annual growth rate of -22.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 726.80M | 95.07% |
| Dec 31, 2024 | 372.58M | -54.41% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
| Oct 20, 2022 | 1.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 811.99B |
| Johnson & Johnson | 450.20B |
| AbbVie | 381.56B |
| UnitedHealth Group | 299.68B |
| AstraZeneca | 253.45B |
| Novartis AG | 240.68B |
| Abbott Laboratories | 218.75B |
| Novo Nordisk | 215.64B |